Literature DB >> 25592188

Cardiovascular Stress Induced by Whole-Body Vibration Exercise in Individuals With Chronic Stroke.

Lin-Rong Liao1, Gabriel Y F Ng2, Alice Y M Jones3, Marco Y C Pang4.   

Abstract

BACKGROUND: Although whole-body vibration (WBV) has sparked tremendous research interest in neurorehabilitation, the cardiovascular responses to WBV in people with stroke remain unknown.
OBJECTIVE: The aim of this study was to determine the acute effects of different WBV protocols on oxygen consumption (V̇o2), heart rate (HR), rate of perceived exertion (RPE), blood pressure (BP), and rate-pressure product (RPP) during the performance of 6 different exercises among people with chronic stroke (time since onset ≥6 months).
DESIGN: A repeated-measures design was used.
METHODS: Each of the 48 participants experienced all 3 WBV protocols in separate sessions: (1) no WBV, (2) low-intensity WBV (peak acceleration=0.96 unit of gravity of Earth [g]), and (3) high-intensity WBV (1.61g). The order in which they encountered the WBV protocols was randomized, as was the order of exercises performed during each session. Oxygen consumption, HR, and RPE were measured throughout the study. Blood pressure and RPP were measured before and after each session.
RESULTS: Low-intensity and high-intensity WBV induced significantly higher V̇o2 by an average of 0.69 and 0.79 mL/kg/min, respectively, compared with the control condition. These protocols also increased HR by an average of 4 bpm. The 2 WBV protocols induced higher RPE than the control condition during static standing exercise only. Although the diastolic and systolic BP and RPP were increased at the end of each exercise session, the addition of WBV had no significant effect on these variables. LIMITATIONS: The results are generalizable only to ambulatory and community-dwelling people with chronic stroke.
CONCLUSIONS: Addition of high- and low-intensity WBV significantly increased the V̇o2 and HR, but the increase was modest. Thus, WBV should not pose any substantial cardiovascular hazard in people with chronic stroke.
© 2015 American Physical Therapy Association.

Entities:  

Mesh:

Year:  2015        PMID: 25592188     DOI: 10.2522/ptj.20140295

Source DB:  PubMed          Journal:  Phys Ther        ISSN: 0031-9023


  6 in total

1.  Effects of whole-body vibration training on lower limb motor function and neural plasticity in patients with stroke: protocol for a randomised controlled clinical trial.

Authors:  Mingkai Zhang; Jianing Wei; Xueping Wu
Journal:  BMJ Open       Date:  2022-06-28       Impact factor: 3.006

2.  Whole Body Vibration Exposure on Markers of Bone Turnover, Body Composition, and Physical Functioning in Breast Cancer Patients Receiving Aromatase Inhibitor Therapy: A Randomized Controlled Trial.

Authors:  Michael K Baker; Carolyn J Peddle-McIntyre; Daniel A Galvão; Catherine Hunt; Nigel Spry; Robert U Newton
Journal:  Integr Cancer Ther       Date:  2018-06-28       Impact factor: 3.279

3.  Effects of Stochastic Resonance Whole-Body Vibration in Individuals with Unilateral Brain Lesion: A Single-Blind Randomized Controlled Trial: Whole-Body Vibration and Neuromuscular Function.

Authors:  Kaspar Herren; Stefan Schmid; Slavko Rogan; Lorenz Radlinger
Journal:  Rehabil Res Pract       Date:  2018-08-01

4.  Whole-body vibration modulates leg muscle reflex and blood perfusion among people with chronic stroke: a randomized controlled crossover trial.

Authors:  Meizhen Huang; Tiev Miller; Michael Ying; Marco Y C Pang
Journal:  Sci Rep       Date:  2020-01-30       Impact factor: 4.379

5.  Effects of different vibration frequencies on muscle strength, bone turnover and walking endurance in chronic stroke.

Authors:  Zhenhui Yang; Tiev Miller; Zou Xiang; Marco Y C Pang
Journal:  Sci Rep       Date:  2021-01-08       Impact factor: 4.379

6.  Metabolic effect of bodyweight whole-body vibration in a 20-min exercise session: A crossover study using verified vibration stimulus.

Authors:  Chiara Milanese; Valentina Cavedon; Marco Sandri; Enrico Tam; Francesco Piscitelli; Federico Boschi; Carlo Zancanaro
Journal:  PLoS One       Date:  2018-01-31       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.